These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11791531)

  • 1. Naltrexone for drinking problems: useful further evidence on efficacy.
    Chick J
    Addiction; 2001 Dec; 96(12):1856. PubMed ID: 11791531
    [No Abstract]   [Full Text] [Related]  

  • 2. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alcohol dependence. Behavior therapy is effective with naltrexone].
    Schmitt-Hönl B
    Med Monatsschr Pharm; 2006 Oct; 29(10):380-1. PubMed ID: 17058899
    [No Abstract]   [Full Text] [Related]  

  • 4. Naltrexone (vivitrol)--a once-monthly injection for alcoholism.
    Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283
    [No Abstract]   [Full Text] [Related]  

  • 5. Naltrexone hydrochloride use in the treatment of alcoholism.
    Ey SR
    West J Med; 1996 Oct; 165(4):227. PubMed ID: 8987434
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of naltrexone in the treatment of alcohol dependence disorder in women].
    Ponce G; Sánchez-García J; Rubio G; Rodríguez-Jiménez R; Jiménez-Arriero MA; Palomo T
    Actas Esp Psiquiatr; 2005; 33(1):13-8. PubMed ID: 15704026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.
    Galloway GP; Koch M; Cello R; Smith DE
    BMC Psychiatry; 2005 Apr; 5():18. PubMed ID: 15804355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone for alcohol dependence: compliance is a key issue.
    O'Brien CP
    Addiction; 2001 Dec; 96(12):1857. PubMed ID: 11791532
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.
    O'Malley SS; Rounsaville BJ; Farren C; Namkoong K; Wu R; Robinson J; O'Connor PG
    Arch Intern Med; 2003 Jul; 163(14):1695-704. PubMed ID: 12885685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
    Baros AM; Latham PK; Moak DH; Voronin K; Anton RF
    Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
    Heilig M
    Lakartidningen; 2002 Jan; 99(3):200-4. PubMed ID: 11838078
    [No Abstract]   [Full Text] [Related]  

  • 14. Current research in the treatment of alcoholism in liver transplant recipients.
    Weinrieb RM; O'Brien CP
    Liver Transpl Surg; 1997 May; 3(3):328-36. PubMed ID: 9346759
    [No Abstract]   [Full Text] [Related]  

  • 15. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
    Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Is there a Spin?
    Naudet F
    Pharmacopsychiatry; 2016 Nov; 49(6):260-261. PubMed ID: 27388712
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers.
    Kranzler HR; Armeli S; Feinn R; Tennen H
    J Consult Clin Psychol; 2004 Apr; 72(2):317-27. PubMed ID: 15065964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vivitrex (Alkermes/Cephalon).
    Heading CE
    Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the use of naltrexone: an integration of preclinical and clinical findings.
    O'Malley SS; Froehlich JC
    Recent Dev Alcohol; 2003; 16():217-45. PubMed ID: 12638640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.